New Investigation Reveals Startling Lack of FDA Oversight in Clinical Trials
#1

According to a new investigation published in The BMJ, experts are raising concerns about the US Food and Drug Administration’s (FDA) insufficient monitoring of clinical trial sites for Covid-19 vaccines and drugs, which were developed at “warp speed.”

The investigation reveals that out of 153 trial sites for Pfizer’s COVID-19 mRNA vaccine, only nine were inspected by the FDA prior to licensing. In addition, just 10 out of 99 trial sites for Moderna and five out of 73 trial sites for remdesivir received inspections from the FDA.


https://scitechdaily.com/endangering-pub...al-trials/
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)